Ireda Q3 Results 2025 Date. Ireda Q3 Results 2024 Date Ashely Merrili Financial Result Ending June Financial Result Ending Sept Financial Result Ending Dec Financial Result Ending March; 2024-25: Q1 (30.06.2024) Q3 (31.12.2024) Special Purpose Interim Financial statement-31.12.2024 : 2023-24: Q1 (30.06.2023) Q2HY1(30.09.2023) Q3 (31.12.2023) Special Purpose Interim Financial statement-31.12.2023: FY & Q4 (31.03.. Key Highlights of Q3 FY 2024-25: Revenue from Operations: Achieved ₹1,698.99 crore, 35.57% increase compared to ₹1,253.20 crore in Q3 FY 2023-24
Ireda Q3 Results 2024 Date Ashely Merrili from arletaykerrill.pages.dev
January 09, 2025, inter-alia to consider and approve the audited financial results of the Company for the quarter ended December 31, 2024. The Board of Directors of IREDA, during a meeting held today, acknowledged the company's outstanding performance and approved the Financial Results for Q3 FY 2024-25
Ireda Q3 Results 2024 Date Ashely Merrili
Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February 13.01.2025 Indian Renew Standalone December 2024 Net Sales at Rs 1,698.45 crore, up 35.57% Y-o-Y IREDA Q3 results: Net profits rise 27% YoY to ?425.35 crore; revenue up 37% 1 min read 09 Jan 2025 Multibagger: This PSU stock gained 430% from IPO price in less than 2 months; details here IREDA Q3 Results: 36% Revenue Growth, 27% Rise in PAT Bengaluru, 9th January 2025 Indian Renewable Energy Development Agency Ltd.
IREDA Share Price Target 2025, 2026, 2027 upto 2030. IREDA Q3 Results: 36% Revenue Growth, 27% Rise in PAT New Delhi, 9th January 2025 Indian Renewable Energy Development Agency Ltd (IREDA) has announced its financial results for the third quarter of FY 202425, showcasing significant growth across key financial metrics
IREDA board approves raising Rs 5000 crore via QIP Industry News The Financial Express. IREDA Q3 Results: IREDA reported a net profit increase of 27% for the December quarter, amounting to Rs 425.38 crore Stocks On Radar: HFCL, Waaree Energies, IREDA, Orchid Pharma in focus on 20 February 13.01.2025 Indian Renew Standalone December 2024 Net Sales at Rs 1,698.45 crore, up 35.57% Y-o-Y